Most brands face a common challenge with claims support: either they dive straight into expensive, time-intensive testing, or they hesitate entirely, assuming the process will be prohibitively complex. Both approaches miss an opportunity to build defensible claims more efficiently.
The smarter approach is tiered testing. It’s a deliberate sequence where each tier answers specific questions and informs whether you move to the next. Done right, it builds defensible claims faster and with far greater confidence than one-off testing.
What Tiered Testing Actually Is
Tiered testing isn’t about doing less testing. It’s about doing the right test at the right time. Tier 1 answers: “Does this ingredient or formulation actually do anything?” Tier 2 answers: “How does it work, and how relevant is that mechanism to real skin?” Tier 3 answers: “Does it work the way we claim in actual human skin conditions?”
You only move to the next tier if the current tier justifies it. You don’t waste time or effort on formulations that fail early screening.
Why This Matters
Most regulatory frameworks for cosmetics don’t require pharma-level proof. They require appropriate evidence. That distinction is critical. A simple chemical screen might be enough to rule out an ingredient. A cell-based model might be enough to substantiate a mechanistic claim. A reconstructed tissue model adds physiological relevance that cell work alone cannot.
Regulators and consumers both understand this. They don’t expect the same evidence level for “contains antioxidants” as for “reverses skin aging.” Tiered testing lets you match evidence type and depth to claim ambition, rather than defaulting to maximum complexity.
There’s another advantage: early screening reduces the need for extensive human patch testing, meaning fewer volunteers are exposed to formulations that haven’t been pre-screened—a win for product safety development and ethics.
How It Works in Practice
Take collagen boosting claims. Tier 1 is a simple chemical screen on the ingredient: does it show activity in a basic assay? If no, the ingredient doesn’t work. Stop. If yes, move to Tier 2.
Tier 2 is a cell-based test on human fibroblasts. Does the ingredient stimulate collagen production in actual skin cells? Does it do so at concentrations relevant to formulation use? Tier 2 answers whether the mechanism is real in a biological system. If results are weak or inconsistent, refinement happens here before moving further. If results are strong, Tier 3 follows.
Tier 3 is testing in reconstructed human skin. This adds the final piece: does collagen activity in cells translate to measurable outcomes in tissue that mimics real skin structure and function? This is where claims like “boosts skin firmness” or “improves elasticity” gain their strongest foundation.
The logic is linear but conditional. You don’t skip tiers. You do stop if evidence doesn’t justify progression.
The Same Pattern Applies Across Claims
Antioxidant claims follow the same structure. Tier 1 chemical screening (ORAC or equivalent) ranks ingredients by free radical scavenging capacity. Tier 2 cell-based testing (OxiSelect using human keratinocytes) shows whether that chemical activity translates to measurable antioxidant effect in cells. Tier 3 reconstructed tissue testing confirms the effect in a physiologically realistic system.
Mildness and gentleness claims use XtraMild as Tier 1 ranking, adding inflammatory biomarker analysis as Tier 2 if the story becomes more complex. Barrier integrity and function claims start with TEER and TEWL measurements, potentially adding lipid profiling or histology as Tier 2 if you need to understand mechanism more deeply.
Why It Speeds Everything Up
Here’s what often happens without tiered testing: A brand formulates three candidates for a collagen claim. Unsure which is best, they run all three to the most sophisticated tissue-level testing available. Weeks later, results arrive. Two candidates show weak activity. One shows promise. The brand has learned which formulation works—but only after extensive, time-consuming work on formulations that didn’t need it.
With tiered testing, all three candidates are screened at Tier 1 simultaneously. Results arrive in days or weeks, not months. Two candidates show weak activity; one shows clear potential. Only the promising candidate advances to Tier 2. By the time you’ve completed Tier 3 on the strongest candidate, you’ve answered all the questions you need. The timeline is tighter. The insights are clearer. The evidence is more focused.
It’s Also About Informed Decision-Making
Tiered testing creates decision points. After Tier 1, you know whether you have a real effect or not. After Tier 2, you understand the mechanism and whether it translates to biological systems. After Tier 3, you have the physiologically relevant data that regulators and consumers increasingly expect.
At each decision point, you make an informed choice: invest further, refine the formulation, or pivot to a different approach. Compare that to running one monolithic test and hoping the results work in your favour. One approach generates confidence through incremental validation. The other is a binary pass/fail that tells you nothing about how to improve if you fail.
Matching Evidence to Claim
The regulatory landscape recognizes this. A claim that an ingredient “is antioxidant” needs less evidence than a claim that a product “reduces visible signs of aging caused by free radical damage.” A claim that a formulation is “mild” needs less evidence infrastructure than a claim that it “restores barrier function to damaged skin.” Tiered testing lets you build evidence architecture proportional to claim scope.
This isn’t cutting corners. It’s being strategic about where evidence matters most and building defensibility efficiently.
What You Need to Get Started
Three things. First, clarity on what you actually want to claim. That determines which evidence tiers are relevant. Second, understanding of what each tier can and cannot tell you—so you choose the right tests in the right sequence. Third, willingness to act on Tier 1 results even if they’re negative. Tiered testing only works if you genuinely let early data inform progression.
The brands getting this right aren’t the ones running the most tests. They’re the ones running the right tests in the right order, making data-driven decisions about where to go deeper, and reaching market with evidence-backed claims faster than competitors still trapped in all-or-nothing testing cycles.
If you’re developing a product with a specific claim and unsure where to begin, get in touch. We can help you map the right evidence sequence for your particular claim and build a testing strategy that answers questions efficiently.
Email info@x-cellr8.com or call +44 (0)1925 607 134.
———
Contact us if you’d like to learn how you can support our mission, become a corporate sponsor or donate to our crowdfunder.
Email info@x-cellr8.com
Call +44 (0)1925 607 134.
Follow Us!